He has a PhD in Physical Chemistry from Uppsala University and has worked with formulation development in a number of fields, e.g. pharma, food and agriculture.
He has led formulation development teams in both Sweden and New Zealand. At RISE, one of the core areas within formulation development is pharmaceutical development and production for Phase 1 clinical trials. Dr Wessman leads, together with Dr Magnus Boman, the strategic work around Precision Medicine within RISE.